Diabetes Drug Cuts Blood Cancer Risk

Diabetes Drug Cuts Blood Cancer Risk

Source: Medscape

In patients with type 2 diabetes, taking GLP-1 drug lowers blood cancer risk.

TOPLINE:
Glucagon-like peptide 1 receptor agonists (GLP-1RA) are linked to a 54% lower risk for developing hematologic cancers than insulin in patients with type 2 diabetes (T2D). The medication shows particular effectiveness in reducing risk for mye… [3251 chars]

Read more